World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
143
Citations
81206
World Ranking
1509
National Ranking
877

Research.com Recognitions

  • 2019 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2008 - Fellow of the American Statistical Association (ASA)

Overview

J. Jack Lee is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their primary field of study is Medicine, with extensive contributions to Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Surgery. Their work spans several main topics, including Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Immunotherapy and Immune Responses, and Statistical Methods in Clinical Trials.

Lee's recent publications cover a variety of significant research areas. Notable papers include:

  • IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves, 2021, BMC Medical Research Methodology
  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, Nature Medicine
  • The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1, 2021, Cancer Cell
  • Global disparities in SARS-CoV-2 genomic surveillance, 2022, Nature Communications
  • Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer, 2021, Journal for ImmunoTherapy of Cancer

Frequent co-authors in Lee's research include John V. Heymach, Don L. Gibbons, Jianjun Zhang, Ignacio I. Wistuba, and Ara A. Vaporciyan.

The scientist has contributed numerous articles to various publication venues with the highest counts in the following journals:

  • Journal of Clinical Oncology (24 publications)
  • Clinical Cancer Research (18 publications)
  • Nature Communications (15 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (11 publications)
  • Cancer Research (11 publications)

Lee is also an author of several book publications, released by different publishers. These include:

  • Corporate Finance and Strategy, 2021, World Scientific
  • Intermediate Futures and Options, 2023, World Scientific
  • Compassionate Capitalism, 2020, Policy Press
  • Compassionate Capitalism, 2020, Bristol University Press eBooks

Awards received by Lee comprise Fellowship of the American Association for the Advancement of Science (AAAS) awarded in 2019 and Fellowship of the American Statistical Association (ASA) awarded in 2008.

Best Publications

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

    Sushrut Kamerkar;Valerie S. LeBleu;Hikaru Sugimoto;Sujuan Yang

  • PROSTATE CANCER RADIATION DOSE RESPONSE: RESULTS OF THE M. D. ANDERSON PHASE III RANDOMIZED TRIAL

    Alan Pollack;Gunar K Zagars;George Starkschall;John A Antolak

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

    Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

    Daniel R. Gomez;Chad Tang;Jianjun Zhang;George R. Blumenschein

  • Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Daniel R Gomez;George R Blumenschein;J Jack Lee;Mike Hernandez

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

    Jianjun Zhang;Junya Fujimoto;Jianhua Zhang;David C. Wedge

  • Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.

    J. A. Roth;D. Nguyen;D. D. Lawrence;B. L. Kemp

  • bcl-2 and p53 Oncoprotein Expression during Colorectal Tumorigenesis

    F. A. Sinicrope;San Bao Ruan;K. R. Cleary;L. C. Stephens

  • Dose Escalation Methods in Phase I Cancer Clinical Trials

    Christophe Le Tourneau;J. Jack Lee;Lillian L. Siu;Lillian L. Siu

  • Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

    Roy S. Herbst;David H. Johnson;Eric Mininberg;David P. Carbone

  • Surgical treatment of multiple brain metastases

    Rajesh K. Bindal;Raymond Sawaya;Milam E. Leavens;J. Jack Lee

  • Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer

    Alan Pollack;Gunar K. Zagars;Lewis G. Smith;Jiun-Kae Jack Lee

  • Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence

  • Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

    Jason K. Sicklick;Shumei Kato;Ryosuke Okamura;Maria Schwaederle

  • Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

    Curtis R. Pickering;Jane H. Zhou;J. Jack Lee;Jennifer A. Drummond

  • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

    Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield

Frequent Co-Authors

Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Scott M. Lippman
Scott M. Lippman University of California, San Diego
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Carmen Behrens
Carmen Behrens The University of Texas MD Anderson Cancer Center
Vassiliki A. Papadimitrakopoulou
Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Li Mao
Li Mao University of Maryland, Baltimore
Reuben Lotan
Reuben Lotan The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Medicine can open flexible and diverse pathways for aspiring healthcare professionals. Many students consider online nursing programs, which can be more accessible and affordable. For example, understanding the average cost of rn to bsn programs helps applicants budget for their education and choose a program that fits their financial situation.

If you have a non-nursing background but want to enter the field quickly, direct entry msn programs for non-nursing majors provide an accelerated pathway to becoming an advanced practice nurse. For those looking for a straightforward admission process, direct admit nursing programs can be less competitive and allow students to start their nursing education without multiple application steps.

Beyond nursing, there are online options in related health fields. Those interested in administrative roles may want to explore medical billing and coding online schools that accept financial aid, which offer skills for essential healthcare support positions. These online pathways offer more flexibility and potentially faster entry into the growing healthcare sector.

Best Scientists Citing J. Jack Lee

Trending Scientists

Recently Published Articles